The AIM-HI Accelerator Fund Recognizes, Honors, and Congratulates Its 2023 Women’s Venture Competition Top Winners

ROCKVILLE, MD, October 16, 2023 – AIM-HI Accelerator Fund is pleased to announce that the winners of the 2023 Women’s Venture Competition are March Biosciences and its CEO, Sarah Hein, Ph.D., as the First Prize with Distinction and Degron Therapeutics and its…

Read more

New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer

Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine…

Read more

Free Cancer Screening Guidelines